MariMed Inc (MRMD)
0.2516
0.00 (0.00%)
USD |
OTCM |
May 17, 15:59
MariMed Price to Book Value: 1.355 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.355 |
| May 16, 2024 | 1.374 |
| May 15, 2024 | 1.368 |
| May 14, 2024 | 1.373 |
| May 13, 2024 | 1.427 |
| May 10, 2024 | 1.413 |
| May 09, 2024 | 1.481 |
| May 08, 2024 | 1.562 |
| May 07, 2024 | 1.588 |
| May 06, 2024 | 1.558 |
| May 03, 2024 | 1.615 |
| May 02, 2024 | 1.603 |
| May 01, 2024 | 1.637 |
| April 30, 2024 | 1.748 |
| April 29, 2024 | 1.453 |
| April 26, 2024 | 1.434 |
| April 25, 2024 | 1.438 |
| April 24, 2024 | 1.391 |
| April 23, 2024 | 1.379 |
| April 22, 2024 | 1.375 |
| April 19, 2024 | 1.453 |
| April 18, 2024 | 1.488 |
| April 17, 2024 | 1.446 |
| April 16, 2024 | 1.458 |
| April 15, 2024 | 1.399 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.358 |
| April 11, 2024 | 1.384 |
| April 10, 2024 | 1.437 |
| April 09, 2024 | 1.378 |
| April 08, 2024 | 1.400 |
| April 05, 2024 | 1.385 |
| April 04, 2024 | 1.347 |
| April 03, 2024 | 1.415 |
| April 02, 2024 | 1.265 |
| April 01, 2024 | 1.352 |
| March 31, 2024 | |
| March 28, 2024 | 1.384 |
| March 27, 2024 | 1.428 |
| March 26, 2024 | 1.366 |
| March 25, 2024 | 1.415 |
| March 22, 2024 | 1.478 |
| March 21, 2024 | 1.350 |
| March 20, 2024 | 1.347 |
| March 19, 2024 | 1.352 |
| March 18, 2024 | 1.442 |
| March 15, 2024 | 1.363 |
| March 14, 2024 | 1.200 |
| March 13, 2024 | 1.109 |
| March 12, 2024 | 1.070 |
| March 11, 2024 | 1.204 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.070
Minimum
Mar 12 2024
233.18
Maximum
Nov 30 2020
12.65
Average
4.294
Median
Price to Book Value Benchmarks
| Emergent BioSolutions Inc | 0.4381 |
| Zymeworks Inc | 1.472 |
| Viemed Healthcare Inc | 2.374 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
Price to Book Value Related Metrics
| PS Ratio | 0.6142 |
| Price | 0.2516 |
| Earnings Yield | -14.35% |
| Market Cap | 95.52M |
| Operating PE Ratio | 7.773 |